Diabetes Disease Management Program
The Diabetes Management Program for the Panama Canal Area Benefit Plan offers a comprehensive approach to diabetes self-management education. We provide a highly individualized program that is customized to your unique needs. We offer all the tools you need to gain control of your diabetes, improve your health and feel your very best. The program is staffed by a multidisciplinary team of diabetes specialists who work closely with you, your physician and other healthcare providers. The Diabetes Management benefit is only available to POS members in the Republic of Panama. However, we have extended the Diabetes Management Program formulary to FFS members of the Plan as of 2010.
Helping You Gain Control Over Diabetes
Modern research has provided an unprecedented range of effective treatments for diabetes, greatly reducing the risks of serious complications. Finding a healthy personal balance -- learning to control your blood sugar levels through a combination of good nutrition, exercise and often medication -- is key to successfully managing your diabetes. Our customized outpatient self-management program includes working closely with your referring healthcare provider; our caring staff will educate you about diabetes, home glucose monitoring, healthy nutrition, appropriate exercise and careful medication management, if needed, so that you can effectively manage your diabetes and enjoy an improved quality of life. Additional programs on special topics are offered periodically, such as healthy eating, heart health and stress management.
Eligibility Requirements for the Diabetes Management Program:
· Member of the Panama Canal Area Benefit Plan
· Diabetes diagnosis established through the diabetes diagnosis protocol
· PCP notification to AXA of the patient’s inclusion in the diabetes program
Available Benefits through the Diabetes Management Program:
· HbA1c at no cost to the patient; every 6 months for patients with results within accepted standards and every 3 months for patients with abnormal results
· Annual determination of fasting lipid profile, including: total cholesterol, HDL, triglycerides and LDL
· Annual microalbuminuria test
· Medication to treat diabetes and its complications as specifically approved by the Plan*
· Counseling and education sessions provided by a physician as approved by the Plan
· Toe nail clipping and foot care every 3 months by the PCP
· Glucometer, lancets and strips as approved by the Plan
Download the Panama Canal Area Benefit Plan "Diabetes Program Prescription Form 2019"
*Only medication to treat diabetes listed on the Plan’s formulary for diabetes are covered at 100% for FFS members in the
Medication Name/Dosage |
Amlodipine 5 mg |
Atenolol 100mg |
Atorvastatina 20mg |
Atorvastatina 10mg |
Candesartan + HCTZ, tabletas de 16/12.5 mg |
Candesartan 16mg |
Enalapril 20mg |
Ezetimibe + Simvastatina 10/20mg |
Fenofibrato 250mg |
Furosemide, 40mg |
Glimepiride 4mg |
Glyburide / Glibenclamida, 5mg |
Hidroclorotiazida/triamterene 25/50mg |
Ibersartan 300mg |
Ibersartan/Hidroclorotiazida 300/12.5mg |
Ibersartan/Hidroclorotiazida 300/25mg |
Insulina Lispro, 100U/mlxvial 10ml |
Insulina, 70/30, vial 10cc |
Insulina, NPH, vial 10cc |
Insulina, reg. Vial 10cc |
Metformin, 500mg |
Metformin, 850mg |
Ramipril 10mg |
Ramipril 5mg |
Rosuvastatina 10mg |
Sitagliptina 100mg |
Controlip 160mg/Fenofibrato 160mg |
Insulina Glargina 100 U.I/ml/Lantus 100 U.I/ml |
Sitagliptina 50mg+Metformina 500mg/Janumet 50 /500mg |
Agujas para plumas de insulina 4mm |
Agujas para plumas de insulina 8mm |
Metformina 50mg liberación prolongada/Glisulin XR 500mg |
2019 Diabetes Management Program Statistics
Below is a summary of the most important statistics of the Diabetes disease management program:
|
2019
|
Members |
2,726 |
|
%
|
Patients with HbA 1 C evaluation
|
82
|
Patients with Lipid Panel
|
70
|
Patients with microalbuminuria evaluation
|
13
|
HbA1C = Glycosylated hemoglobin
Lipid Panel = Cholesterol
HDL COL = high-density lipoprotein cholesterol
TG = triglycerides cholesterol
LDL COL = low-density lipoprotein cholesterol